Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Insulin resistance7794 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A24325 | 22997912 | Ter Arkh | [Clinicopathogenetic characteristics of cardiorenal syndrome in non-alcoholic fatty liver disease]. | 2012 | Details |
| A24326 | 22997724 | Klin Med (Mosk) | [Pathogenetic therapy of metabolic syndrome at the stage of visceral lesions]. | 2012 | Details |
| A24342 | 22983378 | J Pediatr Gastroenterol Nutr | Serum retinol-binding protein 4 is independently associated with pediatric NAFLD and fasting triglyceride level. | 2013 | Details |
| A24345 | 22981383 | Biochem Pharmacol | Endogenously synthesized n-3 polyunsaturated fatty acids in fat-1 mice ameliorate high-fat diet-induced non-alcoholic fatty liver disease. | 2012 | Details |
| A24351 | 22977624 | Exp Ther Med | Effects of insulin resistance and hepatic lipid accumulation on hepatic mRNA expression levels of apoB, MTP and L-FABP in non-alcoholic fatty liver disease. | 2011 | Details |
| A24352 | 22975640 | Clin Biochem | Combinative analysis of factors influence serum alanine aminotransferase activity in adult male population from southern China. | 2012 | Details |
| A24353 | 22974598 | J Pediatr Surg | Patterns of surgical weight loss and resolution of metabolic abnormalities in superobese bariatric adolescents. | 2012 | Details |
| A24359 | 22969777 | Cardiorenal Med | Relationship between Changes in Plasma Adiponectin Concentration and Insulin Sensitivity after Niacin Therapy. | 2012 | Details |
| A24360 | 22969728 | Front Physiol | A Systems Biology Approach to Deciphering the Etiology of Steatosis Employing Patient-Derived Dermal Fibroblasts and iPS Cells. | 2012 | Details |
| A24363 | 22966224 | PPAR Res | Update on pparγ and nonalcoholic Fatty liver disease. | 2012 | Details |
| A24364 | 22965160 | Horm Res Paediatr | Consequences of stopping and restarting leptin in an adolescent with lipodystrophy. | 2012 | Details |
| A24367 | 22964692 | Clin Ter | [Relation of non-alcoholic hepatic steatosis to early carotid atherosclerosis in diet-controlled impaired glucose tolerance subjects]. | 2012 | Details |
| A24368 | 22964626 | Digestion | High prevalence of gastroesophageal reflux symptoms in patients with non-alcoholic fatty liver disease associated with serum levels of triglyceride and cholesterol but not simple visceral obesity. | 2012 | Details |
| A24372 | 22962039 | Pediatr Obes | Analysis of adipokine concentrations in paediatric non-alcoholic fatty liver disease. | 2012 | Details |
| A24374 | 22960889 | Indian J Med Res | Association of pro-inflammatory cytokines, adipokines & oxidative stress with insulin resistance & non-alcoholic fatty liver disease. | 2012 | Details |
| A24375 | 22960565 | J Proteomics | Proteomic analysis of liver mitochondria of apolipoprotein E knockout mice treated with metformin. | 2012 | Details |
| A24376 | 22959976 | Arch Med Res | Population-based risk factors for elevated alanine aminotransferase in a South Texas Mexican-American population. | 2012 | Details |
| A24378 | 22958053 | Aliment Pharmacol Ther | Non-alcoholic fatty liver disease (NAFLD) is associated with low level of physical activity: a population-based study. | 2012 | Details |
| A24379 | 22955994 | Diabetologia | Protection from non-alcoholic steatohepatitis and liver tumourigenesis in high fat-fed insulin receptor substrate-1-knockout mice despite insulin resistance. | 2012 | Details |
| A24383 | 22952059 | Mol Med | Female mice are more susceptible to nonalcoholic fatty liver disease: sex-specific regulation of the hepatic AMP-activated protein kinase-plasminogen activator inhibitor 1 cascade, but not the hepatic endotoxin response. | 2012 | Details |
| A24385 | 22950627 | Scand J Clin Lab Invest | A novel appetite peptide, nesfatin-1 in patients with non-alcoholic fatty liver disease. | 2012 | Details |
| A24386 | 22950055 | Diabetes Metab J | GLP-1 Receptor Agonist and Non-Alcoholic Fatty Liver Disease. | 2012 | Details |
| A24387 | 22949894 | Case Rep Gastroenterol | Dipeptidyl Peptidase IV Inhibitor Improves Insulin Resistance and Steatosis in a Refractory Nonalcoholic Fatty Liver Disease Patient: A Case Report. | 2012 | Details |
| A24390 | 22941955 | Hepatology | Tumor necrosis factor receptor 1 gain-of-function mutation aggravates nonalcoholic fatty liver disease but does not cause insulin resistance in a murine model. | 2013 | Details |
| A24393 | 22940046 | J Hepatol | CYP2E1 and oxidant stress in alcoholic and non-alcoholic fatty liver disease. | 2012 | Details |
| A24394 | 22940028 | Phytomedicine | Liv.52 up-regulates cellular antioxidants and increase glucose uptake to circumvent oleic acid induced hepatic steatosis in HepG2 cells. | 2012 | Details |
| A24401 | 22934096 | Front Immunol | Resolution of inflammation in obesity-induced liver disease. | 2012 | Details |
| A24402 | 22934006 | Front Physiol | Liver fibrogenesis in non-alcoholic steatohepatitis. | 2012 | Details |
| A24403 | 22933860 | Gastroenterol Hepatol (N Y) | Hepatitis C virus infection and nonalcoholic steatohepatitis. | 2012 | Details |
| A24405 | 22932913 | Horm Metab Res | Reversion of steatosis by SREBP-1c antisense oligonucleotide did not improve hepatic insulin action in diet-induced obesity mice. | 2012 | Details |
| A24406 | 22932160 | Eur J Gastroenterol Hepatol | Long-term effects of aerobic plus resistance training on the adipokines and neuropeptides in nonalcoholic fatty liver disease obese adolescents. | 2012 | Details |
| A24422 | 22913901 | Postgrad Med | Managing diabetes in patients with chronic liver disease. | 2012 | Details |
| A24424 | 22912545 | World J Gastroenterol | Overview and developments in noninvasive diagnosis of nonalcoholic fatty liver disease. | 2012 | Details |
| A24429 | 22903613 | Endocrinology | Hepatic insulin signaling changes: possible mechanism in prenatal hypoxia-increased susceptibility of fatty liver in adulthood. | 2012 | Details |
| A24431 | 22902548 | J Hepatol | Exposure to ambient particulate matter induces a NASH-like phenotype and impairs hepatic glucose metabolism in an animal model. | 2012 | Details |
| A24434 | 22899407 | Georgian Med News | [Treatment of nonalcogolic fatty disease of liver]. | 2012 | Details |
| A24435 | 22899406 | Georgian Med News | [Peculiarities of metabolic syndrome and nonalcogolic fatty liver disease in menopausal women]. | 2012 | Details |
| A24438 | 22893453 | Endocr J | Fatty liver as a consequence and cause of insulin resistance: lessons from type 2 diabetic liver. | 2012 | Details |
| A24439 | 22892494 | Intern Med | Long-term branched-chain amino acid supplementation improves glucose tolerance in patients with nonalcoholic steatohepatitis-related cirrhosis. | 2012 | Details |
| A24452 | 22878918 | Dig Dis Sci | Probucol ameliorates the development of nonalcoholic steatohepatitis in rats fed high-fat diets. | 2012 | Details |
| A24455 | 22876924 | Curr Med Chem | Adiponectin: key player in the adipose tissue-liver crosstalk. | 2012 | Details |
| A24458 | 22876038 | World J Gastroenterol | Moro orange juice prevents fatty liver in mice. | 2012 | Details |
| A24459 | 22876027 | World J Gastroenterol | Diagnostic and therapeutic implications of the association between ferritin level and severity of nonalcoholic fatty liver disease. | 2012 | Details |
| A24460 | 22876026 | World J Gastroenterol | Alanine and aspartate aminotransferase and glutamine-cycling pathway: their roles in pathogenesis of metabolic syndrome. | 2012 | Details |
| A24461 | 22875138 | Pediatr Cardiol | The relationship between pediatric nonalcoholic fatty liver disease and cardiovascular risk factors and increased risk of atherosclerosis in obese children. | 2012 | Details |
| A24469 | 22864348 | Yakugaku Zasshi | [Retinoids as promising treatment for non-alcoholic fatty liver disease]. | 2012 | Details |
| A24472 | 22863080 | Liver Int | α-lipoic acid prevents non-alcoholic fatty liver disease in OLETF rats. | 2012 | Details |
| A24476 | 22855698 | World J Hepatol | Lifestyle intervention in non-alcoholic fatty liver disease in Chengyang District, Qingdao, China. | 2012 | Details |
| A24477 | 22855696 | World J Hepatol | Life style modification improves insulin resistance and liver histology in patients with non-alcoholic fatty liver disease. | 2012 | Details |
| A24479 | 22854109 | Metabolism | High-fat, high-fructose diet induces hepatic iron overload via a hepcidin-independent mechanism prior to the onset of liver steatosis and insulin resistance in mice. | 2012 | Details |
| A24483 | 22849970 | Br J Nutr | Beneficial effect of a weight-stable, low-fat/low-saturated fat/low-glycaemic index diet to reduce liver fat in older subjects. | 2012 | Details |
| A24484 | 22848440 | PLoS One | Gallstone disease is associated with more severe liver damage in patients with non-alcoholic fatty liver disease. | 2012 | Details |
| A24498 | 22837189 | J Clin Endocrinol Metab | Polycystic ovary syndrome with hyperandrogenism is characterized by an increased risk of hepatic steatosis compared to nonhyperandrogenic PCOS phenotypes and healthy controls, independent of obesity and insulin resistance. | 2012 | Details |
| A24500 | 22829522 | Diabetes Care | Fatty liver, insulin resistance, and features of metabolic syndrome: relationships with coronary artery calcium in 10,153 people. | 2012 | Details |
| A24501 | 22829450 | Diabetes | Skeletal muscle insulin resistance promotes increased hepatic de novo lipogenesis, hyperlipidemia, and hepatic steatosis in the elderly. | 2012 | Details |
| A24507 | 22824483 | Clin Liver Dis | The cardiovascular link to nonalcoholic fatty liver disease: a critical analysis. | 2012 | Details |
| A24508 | 22824482 | Clin Liver Dis | Is nonalcoholic fatty liver disease in children the same disease as in adults? | 2012 | Details |
| A24511 | 22824479 | Clin Liver Dis | A myriad of pathways to NASH. | 2012 | Details |
| A24524 | 22809960 | Dig Liver Dis | Increased insulinogenic index is an independent determinant of nonalcoholic fatty liver disease activity score in patients with normal glucose tolerance. | 2012 | Details |
| A24527 | 22807031 | Diabetes | Fat-specific DsbA-L overexpression promotes adiponectin multimerization and protects mice from diet-induced obesity and insulin resistance. | 2012 | Details |
| A24532 | 22796347 | Nutr Metab Cardiovasc Dis | Ambulatory arterial stiffness indices and non-alcoholic fatty liver disease in essential hypertension. | 2012 | Details |
| A24535 | 22795319 | Clin Res Hepatol Gastroenterol | Does fructose consumption contribute to non-alcoholic fatty liver disease? | 2012 | Details |
| A24536 | 22792295 | PLoS One | The PNPLA3 rs738409 G-allele associates with reduced fasting serum triglyceride and serum cholesterol in Danes with impaired glucose regulation. | 2012 | Details |
| A24539 | 22789032 | Clin Endocrinol (Oxf) | Fatty liver and insulin resistance in children with hypobetalipoproteinemia: the importance of aetiology. | 2013 | Details |
| A24540 | 22788090 | Rom J Intern Med | Non-alcoholic fatty liver disease and the statins treatment. | 2012 | Details |
| A24543 | 22770622 | Expert Opin Pharmacother | The safety and effectiveness of statins as treatment for HIV-dyslipidemia: the evidence so far and the future challenges. | 2012 | Details |
| A24548 | 22768070 | PLoS One | Palmitoleate induces hepatic steatosis but suppresses liver inflammatory response in mice. | 2012 | Details |
| A24553 | 22753171 | Hepatology | Elovl6 promotes nonalcoholic steatohepatitis. | 2012 | Details |
| A24557 | 22751691 | Diabetes | Effects of aerobic versus resistance exercise without caloric restriction on abdominal fat, intrahepatic lipid, and insulin sensitivity in obese adolescent boys: a randomized, controlled trial. | 2012 | Details |
| A24562 | 22749135 | J Nutr Biochem | The role of dietary fatty acids in the pathology of metabolic syndrome. | 2012 | Details |
| A24563 | 22748277 | Atherosclerosis | Nonalcoholic fatty liver disease is associated with subclinical atherosclerosis independent of obesity and metabolic syndrome in Asian Indians. | 2012 | Details |
| A24567 | 22742899 | Eur J Pharmacol | Carbenoxolone prevents the development of fatty liver in C57BL/6-Lep ob/ob mice via the inhibition of sterol regulatory element binding protein-1c activity and apoptosis. | 2012 | Details |
| A24568 | 22741595 | J Gastroenterol Hepatol | Prevalence and risk factors for non-alcoholic fatty liver disease in Asian people who are not obese. | 2012 | Details |
| A24572 | 22738690 | J Cardiol | The association between impaired collateral circulation and non-alcoholic fatty liver in patients with severe coronary artery disease. | 2012 | Details |
| A24575 | 22735605 | Eur J Gastroenterol Hepatol | How adiponectin, leptin, and ghrelin orchestrate together and correlate with the severity of nonalcoholic fatty liver disease. | 2012 | Details |
| A24576 | 22735219 | Rev Assoc Med Bras (1992) | Association between non-alcoholic fatty liver disease and liver function/injury markers with metabolic syndrome components in class III obese individuals. | 2013 | Details |
| A24577 | 22734967 | Clin Sci (Lond) | Kupffer cell depletion attenuates leptin-mediated methoxamine-stimulated portal perfusion pressure and thromboxane A2 release in a rodent model of NASH-cirrhosis. | 2012 | Details |
| A24579 | 22730920 | Aliment Pharmacol Ther | Review article: non-alcoholic fatty liver disease and osteoporosis--clinical and molecular crosstalk. | 2012 | Details |
| A24585 | 22722431 | Dig Dis | Nonalcoholic fatty liver disease/steatohepatitis: epidemiology, pathogenesis, clinical presentation and treatment. | 2012 | Details |
| A24586 | 22720311 | J Gastrointestin Liver Dis | Is visceral fat reduction necessary to favour metabolic changes in the liver? | 2012 | Details |
| A24591 | 22717644 | Endocrinol Nutr | [Non-alcoholic fatty liver disease and its association with clinical and biochemical variables in obese children and adolescents: effect of a one-year intervention on lifestyle]. | 2012 | Details |
| A24592 | 22717200 | J Acad Nutr Diet | The role of diet and nutrient composition in nonalcoholic Fatty liver disease. | 2012 | Details |
| A24597 | 22710359 | Int J Mol Med | Silymarin suppresses hepatic stellate cell activation in a dietary rat model of non-alcoholic steatohepatitis: analysis of isolated hepatic stellate cells. | 2012 | Details |
| A24600 | 22706738 | Turk J Gastroenterol | Effects of probiotics on methionine choline deficient diet-induced steatohepatitis in rats. | 2012 | Details |
| A24604 | 22700629 | Ann Hepatol |  Correlation of adipose tissue with liver histology in Asian Indian patients with nonalcoholic fatty liver disease (NAFLD). | 2012 | Details |
| A24610 | 22692588 | Int J Mol Med | Curcumin ameliorates mitochondrial dysfunction associated with inhibition of gluconeogenesis in free fatty acid-mediated hepatic lipoapoptosis. | 2012 | Details |
| A24612 | 22691891 | Minerva Endocrinol | Is NAFLD an independent risk factor for increased IMT in T2DM? | 2012 | Details |
| A24613 | 22691278 | BMC Gastroenterol | A low level of serum total testosterone is independently associated with nonalcoholic fatty liver disease. | 2012 | Details |
| A24619 | 22684858 | Hepatology | Nonalcoholic steatohepatitis versus steatosis: adipose tissue insulin resistance and dysfunctional response to fat ingestion predict liver injury and altered glucose and lipoprotein metabolism. | 2012 | Details |
| A24620 | 22684314 | Acta Diabetol | Nonalcoholic fatty liver and metabolic syndrome in Italy: results from a multicentric study of the Italian Arteriosclerosis society. | 2012 | Details |
| A24626 | 22676641 | Clin Endocrinol (Oxf) | Plasma fetuin-A is associated with endothelial dysfunction and subclinical atherosclerosis in subjects with nonalcoholic fatty liver disease. | 2013 | Details |
| A24627 | 22676459 | Cardiovasc Diabetol | Relation between augmentation index and adiponectin during one-year metformin treatment for nonalcoholic steatohepatosis: effects beyond glucose lowering? | 2012 | Details |
| A24629 | 22673924 | Int J Vitam Nutr Res | Therapeutic effect of metformin and vitamin E versus prescriptive diet in obese adolescents with fatty liver. | 2011 | Details |
| A24630 | 22673296 | Endocr J | A case of glycogenic hepatopathy developed in a patient with new-onset fulminant type 1 diabetes: the role of image modalities in diagnosing hepatic glycogen deposition including gradient-dual-echo MRI. | 2012 | Details |
| A24633 | 22672485 | J Am Acad Nurse Pract | Nonalcoholic fatty liver disease: the hepatic metabolic syndrome. | 2012 | Details |
| A24634 | 22672330 | Diabet Med | Dorothy Hodgkin Lecture 2012: non-alcoholic fatty liver disease, insulin resistance and ectopic fat: a new problem in diabetes management. | 2012 | Details |
| A24636 | 22668875 | Eur J Gastroenterol Hepatol | Metabolic syndrome and nonalcoholic fatty liver disease in a Spanish population: influence of the diagnostic criteria used. | 2012 | Details |
| A24637 | 22668639 | J Hepatol | Critical role of cytochrome P450 2E1 (CYP2E1) in the development of high fat-induced non-alcoholic steatohepatitis. | 2012 | Details |
| A24640 | 22661277 | Endocrine | Assessment of endothelial function in patients with nonalcoholic fatty liver disease. | 2012 | Details |
| A24653 | 22646469 | Platelets | Mean platelet volume in biopsy-proven non-alcoholic fatty liver disease. | 2012 | Details |